Trial Outcomes & Findings for Mood and Influenza Vaccine Response: A Feasibility Trial (NCT NCT03144518)

NCT ID: NCT03144518

Last Updated: 2019-07-15

Results Overview

Affective Slider (Betella \& Verschure, 2016), consists of two single item visual analogue scales. Scores for each are presented as a value from 0 to 100 with higher scores indicating greater pleasure (VAS-Valence) and arousal (VAS-Arousal). Positive and Negative Affect Schedule (Watson et al., 1988). Positive and negative affect subscales were created by summing the scores of positive and negative adjectives respectively. For each sub scale, minimum score = 10, maximum score = 50 with higher scores indicating greater positive and negative affect respectively. Pictorial scale of positive affect (unvalidated, internally developed). Participants completed a single-item photo-based measure of positive affect tailored for older adults. Participants were presented with six groups of images depicting varying degrees of positive affect, and indicate which best reflected how they felt at that moment. Minumum score 1, maximum score 6, higher scores indicate greater positive affect.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

106 participants

Primary outcome timeframe

Baseline, Immediately Post Intervention (i.e, 15 minutes post-baseline).

Results posted on

2019-07-15

Participant Flow

Note: 3 Participants were not randomised to condition, as they did not attend primary session.

Participant milestones

Participant milestones
Measure
Experimental
Participants in the experimental condition will view a video designed to induce positive affect. This includes 3 short comedy clips (fork handles sketch, the two Ronnie's; A room with a view - faulty towers; Tim Vine Live stand-up extract), uplifting music (Jailhouse Rock - Elvis Presley; Happy Together - The Turtles), jokes and positive imagery. The content of the intervention has been informed by patient and public involvement, focus groups with older adults, and pilot testing. Positive Affect Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Active Control
Participants in the control condition will view a video of matched length to the experimental condition video, but not designed to induce mood change. This includes short documentary clips (a pride in pencils; model railways, lecture extract on hydration), neutral music and images. Neutral Control Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Primary Outcome (Mood)
STARTED
52
51
Primary Outcome (Mood)
COMPLETED
52
51
Primary Outcome (Mood)
NOT COMPLETED
0
0
4 Weeks Post-Vaccination
STARTED
52
51
4 Weeks Post-Vaccination
COMPLETED
51
51
4 Weeks Post-Vaccination
NOT COMPLETED
1
0
16 Week Post-Vaccination
STARTED
52
51
16 Week Post-Vaccination
COMPLETED
49
49
16 Week Post-Vaccination
NOT COMPLETED
3
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Missing Data count n=1

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Experimental
n=52 Participants
Participants in the experimental condition will view a video designed to induce positive affect. This includes 3 short comedy clips (fork handles sketch, the two Ronnie's; A room with a view - faulty towers; Tim Vine Live stand-up extract), uplifting music (Jailhouse Rock - Elvis Presley; Happy Together - The Turtles), jokes and positive imagery. The content of the intervention has been informed by patient and public involvement, focus groups with older adults, and pilot testing. Positive Affect Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Active Control
n=51 Participants
Participants in the control condition will view a video of matched length to the experimental condition video, but not designed to induce mood change. This includes short documentary clips (a pride in pencils; model railways, lecture extract on hydration), neutral music and images. Neutral Control Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Total
n=103 Participants
Total of all reporting groups
Age, Continuous
72.6 years
STANDARD_DEVIATION 4.6 • n=52 Participants • Missing Data count n=1
73.3 years
STANDARD_DEVIATION 5.1 • n=50 Participants • Missing Data count n=1
72.95 years
STANDARD_DEVIATION 4.87 • n=102 Participants • Missing Data count n=1
Sex: Female, Male
Female
22 Participants
n=52 Participants
30 Participants
n=51 Participants
52 Participants
n=103 Participants
Sex: Female, Male
Male
30 Participants
n=52 Participants
21 Participants
n=51 Participants
51 Participants
n=103 Participants
Race/Ethnicity, Customized
White
51 Participants
n=52 Participants
48 Participants
n=51 Participants
99 Participants
n=103 Participants
Race/Ethnicity, Customized
Asian
0 Participants
n=52 Participants
1 Participants
n=51 Participants
1 Participants
n=103 Participants
Race/Ethnicity, Customized
Black
1 Participants
n=52 Participants
1 Participants
n=51 Participants
2 Participants
n=103 Participants
Race/Ethnicity, Customized
Did not Respond
0 Participants
n=52 Participants
1 Participants
n=51 Participants
1 Participants
n=103 Participants
Marital Status
Married
34 Participants
n=52 Participants
29 Participants
n=51 Participants
63 Participants
n=103 Participants
Marital Status
Single, never married
0 Participants
n=52 Participants
3 Participants
n=51 Participants
3 Participants
n=103 Participants
Marital Status
Separated/divorced
9 Participants
n=52 Participants
4 Participants
n=51 Participants
13 Participants
n=103 Participants
Marital Status
Widowed
4 Participants
n=52 Participants
8 Participants
n=51 Participants
12 Participants
n=103 Participants
Marital Status
Cohabiting
3 Participants
n=52 Participants
3 Participants
n=51 Participants
6 Participants
n=103 Participants
Marital Status
Did not Respond
2 Participants
n=52 Participants
4 Participants
n=51 Participants
6 Participants
n=103 Participants
Highest Level of Education
School
37 Participants
n=52 Participants
40 Participants
n=51 Participants
77 Participants
n=103 Participants
Highest Level of Education
Undergraduate
2 Participants
n=52 Participants
0 Participants
n=51 Participants
2 Participants
n=103 Participants
Highest Level of Education
Postgraduate
0 Participants
n=52 Participants
1 Participants
n=51 Participants
1 Participants
n=103 Participants
Highest Level of Education
Other
8 Participants
n=52 Participants
8 Participants
n=51 Participants
16 Participants
n=103 Participants
Highest Level of Education
Did not respond
5 Participants
n=52 Participants
2 Participants
n=51 Participants
7 Participants
n=103 Participants
Independent Living
Yes
47 Participants
n=52 Participants
49 Participants
n=51 Participants
96 Participants
n=103 Participants
Independent Living
No
5 Participants
n=52 Participants
2 Participants
n=51 Participants
7 Participants
n=103 Participants
Highest Ever Total Household Income
≤ £14,999
17 Participants
n=52 Participants
16 Participants
n=51 Participants
33 Participants
n=103 Participants
Highest Ever Total Household Income
£15,000-£24,999
16 Participants
n=52 Participants
17 Participants
n=51 Participants
33 Participants
n=103 Participants
Highest Ever Total Household Income
£25,000-£34,999
8 Participants
n=52 Participants
4 Participants
n=51 Participants
12 Participants
n=103 Participants
Highest Ever Total Household Income
£35,000-£49,000
7 Participants
n=52 Participants
5 Participants
n=51 Participants
12 Participants
n=103 Participants
Highest Ever Total Household Income
£50,000-£74,999
1 Participants
n=52 Participants
2 Participants
n=51 Participants
3 Participants
n=103 Participants
Highest Ever Total Household Income
£75,000-£99,000
0 Participants
n=52 Participants
0 Participants
n=51 Participants
0 Participants
n=103 Participants
Highest Ever Total Household Income
≥ £100,000
0 Participants
n=52 Participants
0 Participants
n=51 Participants
0 Participants
n=103 Participants
Highest Ever Total Household Income
Did Not Respond
3 Participants
n=52 Participants
7 Participants
n=51 Participants
10 Participants
n=103 Participants
Current Smoker
4 Participants
n=52 Participants
4 Participants
n=51 Participants
8 Participants
n=103 Participants
Total Health Status
555.7 units on a scale
STANDARD_DEVIATION 175.1 • n=49 Participants • Missing Data Count: n=6
555.1 units on a scale
STANDARD_DEVIATION 169.9 • n=48 Participants • Missing Data Count: n=6
555.41 units on a scale
STANDARD_DEVIATION 171.62 • n=97 Participants • Missing Data Count: n=6
Trait Positive Affect
33.5 units on a scale
STANDARD_DEVIATION 8.6 • n=50 Participants • Missing Data Count: n=8
33.8 units on a scale
STANDARD_DEVIATION 8.1 • n=45 Participants • Missing Data Count: n=8
33.65 units on a scale
STANDARD_DEVIATION 8.33 • n=95 Participants • Missing Data Count: n=8
Trait Optimism
16.0 units on a scale
STANDARD_DEVIATION 4.8 • n=50 Participants • Missing Data Count: n=7
15.3 units on a scale
STANDARD_DEVIATION 4.5 • n=46 Participants • Missing Data Count: n=7
15.68 units on a scale
STANDARD_DEVIATION 4.61 • n=96 Participants • Missing Data Count: n=7
Trait Emotional Reactivity
39.9 units on a scale
STANDARD_DEVIATION 17.2 • n=47 Participants • Missing Data Count: n=8
41.3 units on a scale
STANDARD_DEVIATION 16.0 • n=48 Participants • Missing Data Count: n=8
40.59 units on a scale
STANDARD_DEVIATION 16.52 • n=95 Participants • Missing Data Count: n=8
Pre-Vaccination IgG
A/Michigan
187.2 ug/ml
STANDARD_DEVIATION 112.4 • n=52 Participants
156.6 ug/ml
STANDARD_DEVIATION 103.1 • n=51 Participants
172.05 ug/ml
STANDARD_DEVIATION 108.47 • n=103 Participants
Pre-Vaccination IgG
A/Hong-Kong
238.0 ug/ml
STANDARD_DEVIATION 119.9 • n=52 Participants
241.0 ug/ml
STANDARD_DEVIATION 158.1 • n=51 Participants
239.50 ug/ml
STANDARD_DEVIATION 139.42 • n=103 Participants
Pre-Vaccination IgG
B/Brisbane
107.0 ug/ml
STANDARD_DEVIATION 54.1 • n=52 Participants
118.9 ug/ml
STANDARD_DEVIATION 78.7 • n=51 Participants
112.90 ug/ml
STANDARD_DEVIATION 67.35 • n=103 Participants
Pre-Vaccination IgG
B/Phuket
144.4 ug/ml
STANDARD_DEVIATION 85.1 • n=52 Participants
183.2 ug/ml
STANDARD_DEVIATION 146.2 • n=51 Participants
163.61 ug/ml
STANDARD_DEVIATION 117.93 • n=103 Participants
Trait Negative Affect
15.2 units on a scale
STANDARD_DEVIATION 6.7 • n=49 Participants • Missing Data Count n=11
15.5 units on a scale
STANDARD_DEVIATION 6.4 • n=43 Participants • Missing Data Count n=11
15.35 units on a scale
STANDARD_DEVIATION 6.52 • n=92 Participants • Missing Data Count n=11

PRIMARY outcome

Timeframe: Baseline, Immediately Post Intervention (i.e, 15 minutes post-baseline).

Population: Missing Data for some outcome measures - i.e., incomplete scale

Affective Slider (Betella \& Verschure, 2016), consists of two single item visual analogue scales. Scores for each are presented as a value from 0 to 100 with higher scores indicating greater pleasure (VAS-Valence) and arousal (VAS-Arousal). Positive and Negative Affect Schedule (Watson et al., 1988). Positive and negative affect subscales were created by summing the scores of positive and negative adjectives respectively. For each sub scale, minimum score = 10, maximum score = 50 with higher scores indicating greater positive and negative affect respectively. Pictorial scale of positive affect (unvalidated, internally developed). Participants completed a single-item photo-based measure of positive affect tailored for older adults. Participants were presented with six groups of images depicting varying degrees of positive affect, and indicate which best reflected how they felt at that moment. Minumum score 1, maximum score 6, higher scores indicate greater positive affect.

Outcome measures

Outcome measures
Measure
Experimental
n=52 Participants
Participants in the experimental condition will view a video designed to induce positive affect. This includes 3 short comedy clips (fork handles sketch, the two Ronnie's; A room with a view - faulty towers; Tim Vine Live stand-up extract), uplifting music (Jailhouse Rock - Elvis Presley; Happy Together - The Turtles), jokes and positive imagery. The content of the intervention has been informed by patient and public involvement, focus groups with older adults, and pilot testing. Positive Affect Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Active Control
n=51 Participants
Participants in the control condition will view a video of matched length to the experimental condition video, but not designed to induce mood change. This includes short documentary clips (a pride in pencils; model railways, lecture extract on hydration), neutral music and images. Neutral Control Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Mood Outcome Scores [Multiple]
Post-Intervention VAS-Valence
87.4 score on a scale
Standard Deviation 15.7
79.8 score on a scale
Standard Deviation 20.8
Mood Outcome Scores [Multiple]
Post-Intervention VAS-Arousal
83.7 score on a scale
Standard Deviation 16.8
79.8 score on a scale
Standard Deviation 20.3
Mood Outcome Scores [Multiple]
Post-Intervention Pictorial Scale
4.7 score on a scale
Standard Deviation 1.1
4.0 score on a scale
Standard Deviation 1.5
Mood Outcome Scores [Multiple]
Post-Intervention PANAS Positive Affect
35.0 score on a scale
Standard Deviation 8.4
35.0 score on a scale
Standard Deviation 7.6
Mood Outcome Scores [Multiple]
Post-Intervention PANAS Negative Affect
11.1 score on a scale
Standard Deviation 3.0
11.4 score on a scale
Standard Deviation 2.3
Mood Outcome Scores [Multiple]
Pre-Intervention VAS-Valence
79.5 score on a scale
Standard Deviation 19.2
80.5 score on a scale
Standard Deviation 18.1
Mood Outcome Scores [Multiple]
Pre-Intervention VAS-Arousal
79.9 score on a scale
Standard Deviation 19.0
80.9 score on a scale
Standard Deviation 20.1
Mood Outcome Scores [Multiple]
Pre-Intervention Pictorial
3.7 score on a scale
Standard Deviation 1.5
4.0 score on a scale
Standard Deviation 1.5
Mood Outcome Scores [Multiple]
Pre-Intervention PANAS Postive Affect
34.3 score on a scale
Standard Deviation 7.2
34.6 score on a scale
Standard Deviation 35.0
Mood Outcome Scores [Multiple]
Pre-Intervention PANAS Negative Affect
12.3 score on a scale
Standard Deviation 4.0
12.3 score on a scale
Standard Deviation 4.0

SECONDARY outcome

Timeframe: Baseline

Population: Total Population that received study Invitation

Recruitment rates to inform a future definitive trial

Outcome measures

Outcome measures
Measure
Experimental
n=1131 Participants
Participants in the experimental condition will view a video designed to induce positive affect. This includes 3 short comedy clips (fork handles sketch, the two Ronnie's; A room with a view - faulty towers; Tim Vine Live stand-up extract), uplifting music (Jailhouse Rock - Elvis Presley; Happy Together - The Turtles), jokes and positive imagery. The content of the intervention has been informed by patient and public involvement, focus groups with older adults, and pilot testing. Positive Affect Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Active Control
Participants in the control condition will view a video of matched length to the experimental condition video, but not designed to induce mood change. This includes short documentary clips (a pride in pencils; model railways, lecture extract on hydration), neutral music and images. Neutral Control Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Recruitment
Expressed Interest, but not consented
23 Participants
Recruitment
Consented, but not randomised
3 Participants
Recruitment
Randomised
103 Participants
Recruitment
Did Not Express Interest
1002 Participants

SECONDARY outcome

Timeframe: 4 weeks (post-vaccination), 16 Weeks (post-vaccination)

Attrition - to inform a future definitive trial

Outcome measures

Outcome measures
Measure
Experimental
n=52 Participants
Participants in the experimental condition will view a video designed to induce positive affect. This includes 3 short comedy clips (fork handles sketch, the two Ronnie's; A room with a view - faulty towers; Tim Vine Live stand-up extract), uplifting music (Jailhouse Rock - Elvis Presley; Happy Together - The Turtles), jokes and positive imagery. The content of the intervention has been informed by patient and public involvement, focus groups with older adults, and pilot testing. Positive Affect Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Active Control
n=51 Participants
Participants in the control condition will view a video of matched length to the experimental condition video, but not designed to induce mood change. This includes short documentary clips (a pride in pencils; model railways, lecture extract on hydration), neutral music and images. Neutral Control Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Attrition
Attendance at 4 Week Follow-up · Yes
51 Participants
51 Participants
Attrition
Attendance at 4 Week Follow-up · No
1 Participants
0 Participants
Attrition
Attendance at 16 Week Follow up · Yes
49 Participants
48 Participants
Attrition
Attendance at 16 Week Follow up · No
3 Participants
3 Participants

SECONDARY outcome

Timeframe: Baseline, Immediately Post Intervention (i.e, 15 minutes post-baseline).

Population: Missing Data Count n=15

Secretory IgA levels measured in saliva samples via ELISA. This is a non-specific measure of immunological response

Outcome measures

Outcome measures
Measure
Experimental
n=46 Participants
Participants in the experimental condition will view a video designed to induce positive affect. This includes 3 short comedy clips (fork handles sketch, the two Ronnie's; A room with a view - faulty towers; Tim Vine Live stand-up extract), uplifting music (Jailhouse Rock - Elvis Presley; Happy Together - The Turtles), jokes and positive imagery. The content of the intervention has been informed by patient and public involvement, focus groups with older adults, and pilot testing. Positive Affect Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Active Control
n=42 Participants
Participants in the control condition will view a video of matched length to the experimental condition video, but not designed to induce mood change. This includes short documentary clips (a pride in pencils; model railways, lecture extract on hydration), neutral music and images. Neutral Control Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Secretory IgA Response
Pre-Intervention Flow Rate
81.0 Flow Rate (ug/min)
Standard Deviation 76.4
94.1 Flow Rate (ug/min)
Standard Deviation 94.2
Secretory IgA Response
Post-Intervention Flow Rate
116.7 Flow Rate (ug/min)
Standard Deviation 107.5
144.7 Flow Rate (ug/min)
Standard Deviation 142.5

SECONDARY outcome

Timeframe: 4 weeks (post-vaccination), 16 Weeks (post-vaccination)

Population: Missing Data Count: n=1 for 4 weeks post-vaccination, n=5 for 16 weeks post-vaccination

IgG levels against the 4 vaccine strains measured via ELISA. Values represent equivalent ug/ml based on diluted sample absorbance value interpolation against a standard IgG curve, multiplied by the serum dilution score (i.e., 4000).

Outcome measures

Outcome measures
Measure
Experimental
n=52 Participants
Participants in the experimental condition will view a video designed to induce positive affect. This includes 3 short comedy clips (fork handles sketch, the two Ronnie's; A room with a view - faulty towers; Tim Vine Live stand-up extract), uplifting music (Jailhouse Rock - Elvis Presley; Happy Together - The Turtles), jokes and positive imagery. The content of the intervention has been informed by patient and public involvement, focus groups with older adults, and pilot testing. Positive Affect Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Active Control
n=51 Participants
Participants in the control condition will view a video of matched length to the experimental condition video, but not designed to induce mood change. This includes short documentary clips (a pride in pencils; model railways, lecture extract on hydration), neutral music and images. Neutral Control Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Vaccine Specific IgG Response
16 Weeks Post-Vaccination A/Hong-Kong
283.67 ug/ml
Standard Deviation 126.72
288.75 ug/ml
Standard Deviation 180.18
Vaccine Specific IgG Response
4 Weeks Post-Vaccination A/Michigan
243.28 ug/ml
Standard Deviation 134.52
208.81 ug/ml
Standard Deviation 122.42
Vaccine Specific IgG Response
4 Weeks Post-Vaccination A/Hong-Kind
301.68 ug/ml
Standard Deviation 138.88
284.96 ug/ml
Standard Deviation 138.64
Vaccine Specific IgG Response
4 Weeks Post-Vaccination B/Brisbane
126.30 ug/ml
Standard Deviation 56.36
127.25 ug/ml
Standard Deviation 63.93
Vaccine Specific IgG Response
4 Weeks Post-Vaccination B/Phuket
210.30 ug/ml
Standard Deviation 123.96
229.57 ug/ml
Standard Deviation 135.63
Vaccine Specific IgG Response
16 Weeks Post-Vaccination A/Michigan
221.69 ug/ml
Standard Deviation 131.90
203.03 ug/ml
Standard Deviation 119.41
Vaccine Specific IgG Response
16 Weeks Post-Vaccination B/Brisbane
139.49 ug/ml
Standard Deviation 56.40
144.47 ug/ml
Standard Deviation 76.77
Vaccine Specific IgG Response
16 Weeks Post-Vaccination B/Phuket
249.10 ug/ml
Standard Deviation 124.90
271.70 ug/ml
Standard Deviation 176.16

SECONDARY outcome

Timeframe: Baseline to 6 months post-vaccination

Via medical records, we assessed health care usage potentially attributable to flu-like symptoms (e.g., GP visits, hospitalisation, antibiotic prescription) during the 6 months post-vaccination

Outcome measures

Outcome measures
Measure
Experimental
n=52 Participants
Participants in the experimental condition will view a video designed to induce positive affect. This includes 3 short comedy clips (fork handles sketch, the two Ronnie's; A room with a view - faulty towers; Tim Vine Live stand-up extract), uplifting music (Jailhouse Rock - Elvis Presley; Happy Together - The Turtles), jokes and positive imagery. The content of the intervention has been informed by patient and public involvement, focus groups with older adults, and pilot testing. Positive Affect Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Active Control
n=51 Participants
Participants in the control condition will view a video of matched length to the experimental condition video, but not designed to induce mood change. This includes short documentary clips (a pride in pencils; model railways, lecture extract on hydration), neutral music and images. Neutral Control Intervention: See Previous Description Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care): Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)
Health Care Utilization
GP Consultations
14 Participants
13 Participants
Health Care Utilization
Nurse Consultations
1 Participants
1 Participants
Health Care Utilization
Out of Hours/Telephone Conversations
7 Participants
3 Participants
Health Care Utilization
Emergency Department Consultations
1 Participants
1 Participants
Health Care Utilization
Antibiotic Prescriptions
6 Participants
9 Participants
Health Care Utilization
Additional Investigations (e.g., Xray)
4 Participants
3 Participants

Adverse Events

Experimental

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Active Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr Kieran Ayling

University of Nottingham

Phone: +44 1158466908

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place